Onconova Therapeutics Inc... (ONTX)
NASDAQ: ONTX
· Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Apr 02, 2024, 10:00 PM
Onconova Therapeutics Revenue
Onconova Therapeutics reported an annual revenue of $226B, reflecting a 99999900% growth. For the quarter ending March 31, 2025, Onconova Therapeutics generated $57M in revenue.
Revenue (ttm)
226B
Revenue Growth
99999900%
Price / Sales Ratio
0
Revenue / Employee
14.13B
Employees
16
Market Cap
20.9M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 226B | +99999900.00% |
| Dec 31, 2023 | 226K | n/a |
| Dec 31, 2022 | 226K | n/a |
| Dec 31, 2021 | 226K | -2.16% |
| Dec 31, 2020 | 231K | -89.42% |
| Dec 31, 2019 | 2.18M | +77.77% |
| Dec 31, 2018 | 1.23M | +56.04% |
| Dec 31, 2017 | 787K | -85.81% |
| Dec 31, 2016 | 5.55M | -51.59% |
| Dec 31, 2015 | 11.46M | +1332.00% |
| Dec 31, 2014 | 800K | -83.17% |
| Dec 31, 2013 | 4.75M | -89.71% |
| Dec 31, 2012 | 46.19M | +3006.25% |
| Dec 31, 2011 | 1.49M | n/a |